Wang; Gary T.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wang; Gary T..The latest application filed is for "apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases".

Company Profile

8.43.53

Wang; Gary T. - Libertyville IL
Wang; Gary T. - Niles IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20210221789 - Bruncko; Milan ; et al.	2021-07-22
Tolypocladium album strain Grant 10,945,443 - Vinuesa Navarro , et al. March 16, 2	2021-03-16
Methods Of Controlling Pests Using Terpendoles App 20200352169 - Branscome; Deanna ; et al.	2020-11-12
Methods of controlling pests using terpendoles Grant 10,729,135 - Branscome , et al.	2020-08-04
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20200231566 - Bruncko; Milan ; et al.	2020-07-23
(S)-abscisic acid derivatives for improving plant stress tolerance Grant 10,314,307 - Silverman , et al.	2019-06-11
3'-substituted-abscisic acid derivatives Grant 10,299,476 - Wang , et al.	2019-05-28
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20190119247 - Bruncko; Milan ; et al.	2019-04-25
Methods Of Controlling Pests Using Terpendoles App 20190098900 - Branscome; Deanna ; et al.	2019-04-04
Novel Tolypocladium Album Strain App 20190098904 - Vinuesa Navarro; Maria de los Angeles ; et al.	2019-04-04
1-aminocyclopropane-1-carboxylic Acid Polymorphs App 20180282260 - Kawamura; Mitsunobu ; et al.	2018-10-04
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20180251426 - Bruncko; Milan ; et al.	2018-09-06
(S)-abscisic acid derivatives for enhanced grape coloration Grant 9,877,480 - Woolard , et al. January 30, 2	2018-01-30
(S)-abscisic acid derivatives for thinning Grant 9,872,492 - Woolard , et al. January 23, 2	2018-01-23
3'-substituted-abscisic Acid Derivatives App 20170360037 - Wang; Gary T. ; et al.	2017-12-21
3'-substituted-abscisic acid derivatives Grant 9,781,930 - Wang , et al. October 10, 2	2017-10-10
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20170158666 - Bruncko; Milan ; et al.	2017-06-08
(s)-abscisic Acid Derivatives For Thinning App 20160338352 - Woolard; Derek D. ; et al.	2016-11-24
(s)-abscisic Acid Derivatives For Improving Plant Stress Tolerance App 20160338353 - Silverman; Franklin Paul ; et al.	2016-11-24
(s)-abscisic Acid Derivatives For Enhanced Grape Coloration App 20160338351 - Woolard; Derek D. ; et al.	2016-11-24
(s)-abscisic Acid Derivatives For Enhanced Fruit And Vegetable Coloration App 20160338354 - Woolard; Derek D. ; et al.	2016-11-24
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20160304451 - Elmore; Steven W. ; et al.	2016-10-20
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 9,303,025 - Bruncko , et al. April 5, 2	2016-04-05
3'-substituted-abscisic Acid Derivatives App 20160007598 - Wang; Gary T. ; et al.	2016-01-14
Apoptosis-inducing Agent For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20160002187 - Kunzer; Aaron R. ; et al.	2016-01-07
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20150329541 - Bruncko; Milan ; et al.	2015-11-19
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 9,174,982 - Bruncko , et al. November 3, 2	2015-11-03
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 9,156,856 - Kunzer , et al. October 13, 2	2015-10-13
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 9,125,913 - Bruncko , et al. September 8, 2	2015-09-08
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 9,072,748 - Bruncko , et al. July 7, 2	2015-07-07
BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 9,073,855 - Doherty , et al. July 7, 2	2015-07-07
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20150183775 - BRUNCKO; Milan ; et al.	2015-07-02
Imidazopyridines as a novel scaffold for multi-targeted kinase inhibition Grant 9,051,315 - Ba-maung , et al. June 9, 2	2015-06-09
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 9,045,420 - Doherty , et al. June 2, 2	2015-06-02
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 9,034,875 - Doherty , et al. May 19, 2	2015-05-19
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 9,029,404 - Doherty , et al. May 12, 2	2015-05-12
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20140113910 - Bruncko; Milan ; et al.	2014-04-24
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20140107119 - Bruncko; Milan ; et al.	2014-04-17
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20140094471 - Bruncko; Milan ; et al.	2014-04-03
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20140088106 - Bruncko; Milan ; et al.	2014-03-27
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20140066621 - Bruncko; Milan ; et al.	2014-03-06
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20140057890 - Bruncko; Milan ; et al.	2014-02-27
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20140057889 - Bruncko; Milan ; et al.	2014-02-27
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 8,586,754 - Bruncko , et al. November 19, 2	2013-11-19
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 8,580,794 - Doherty , et al. November 12, 2	2013-11-12
Bcl-2 Selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20130296295 - BRUNCKO; Milan ; et al.	2013-11-07
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 8,563,735 - Bruncko , et al. October 22, 2	2013-10-22
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 8,557,983 - Doherty , et al. October 15, 2	2013-10-15
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20130267534 - Bruncko; Milan ; et al.	2013-10-10
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20130267514 - Bruncko; Milan ; et al.	2013-10-10
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 8,546,399 - Bruncko , et al. October 1, 2	2013-10-01
Pyrimidine inhibitors of kinase activity Grant 8,536,180 - Clark , et al. September 17, 2	2013-09-17
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20130184278 - KUNZER; Aaron R. ; et al.	2013-07-18
Pyrimidine inhibitors of kinase activity Grant 8,486,933 - Wang , et al. July 16, 2	2013-07-16
Pyrimidine inhibitors of kinase activity Grant 8,354,422 - Clark , et al. January 15, 2	2013-01-15
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 8,338,466 - Kunzer , et al. December 25, 2	2012-12-25
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20120190688 - Bruncko; Milan ; et al.	2012-07-26
Protein kinase inhibitors Grant 8,067,409 - Ba-Maung , et al. November 29, 2	2011-11-29
Imidazopyridines As A Novel Scaffold For Multi-targeted Kinase Inhibition App 20110124632 - Ba-maung; Nwe Y. ; et al.	2011-05-26
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20110124628 - Bruncko; Milan ; et al.	2011-05-26
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20100305122 - Bruncko; Milan ; et al.	2010-12-02
Pyrimidine Inhibitors of Kinase Activity App 20100305126 - Clark; Richard F. ; et al.	2010-12-02
Pyrimidine Inhibitors Of Kinase Activity App 20100305118 - Clark; Richard F. ; et al.	2010-12-02
Pyrimidine Inhibitors Of Kinase Activity App 20100305112 - Wang; Gary T. ; et al.	2010-12-02
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20100298323 - Bruncko; Milan ; et al.	2010-11-25
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20100298321 - Bruncko; Milan ; et al.	2010-11-25
Substituted pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors Grant 7,772,231 - Sheppard , et al. August 10, 2	2010-08-10
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20100184766 - Kunzer; Aaron R. ; et al.	2010-07-22
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20100160322 - Bruncko; Milan ; et al.	2010-06-24
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20100152183 - Bruncko; Milan ; et al.	2010-06-17
Protein Kinase Inhibitors App 20090253723 - Ba-Maung; Nwe Y. ; et al.	2009-10-08
Sulfonamides having antiangiogenic and anticancer activity Grant 7,491,718 - Comess , et al. February 17, 2	2009-02-17
Protein Kinase Inhibitors App 20070203143 - Sheppard; George S. ; et al.	2007-08-30
Aryl Phenylheterocyclyl Sulfide Derivatives And Their Use As Cell Adhesion-inhibiting Anti-inflammatory And Immune-suppressive Agents App 20070066585 - Wang; Gary T. ; et al.	2007-03-22
Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents Grant 7,129,247 - Wang , et al. October 31, 2	2006-10-31
Urea kinase inhibitors Grant 7,056,925 - Li , et al. June 6, 2	2006-06-06
Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-supressive agents App 20050014746 - Wang, Gary T. ; et al.	2005-01-20
Urea kinase inhibitors App 20040259885 - Li, Gaoquan ; et al.	2004-12-23
Inhibitors of neuraminidases Grant 6,831,096 - Maring , et al. December 14, 2	2004-12-14
Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents Grant 6,787,542 - Wang , et al. September 7, 2	2004-09-07
Sulfonamides having antiangiogenic and anticancer activity App 20040167128 - Comess, Kenneth M. ; et al.	2004-08-26
Sulfonamides having antiangiogenic and anticancer activity App 20040157836 - Comess, Kenneth M. ; et al.	2004-08-12
Inhibitors of neuraminidases App 20040097471 - Maring, Clarence J. ; et al.	2004-05-20
Urea kinase inhibitors App 20040034038 - Li, Goaquan ; et al.	2004-02-19
Inhibitors of neuraminidases Grant 6,455,571 - Maring , et al. September 24, 2	2002-09-24
Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents App 20020132807 - Wang, Gary T. ; et al.	2002-09-19
Substituted phenyl farnesyltransferase inhibitors App 20020019527 - Wang, Wei-Bo ; et al.	2002-02-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.